Access to anti-retroviral drugs, female in South Africa
South Africa: Access to anti-retroviral drugs, female was 84.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in South Africa, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in South Africa is 84.0%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 1.2% on the previous year and up 61.5% over ten years.
Over the whole period, access to anti-retroviral drugs, female in South Africa peaked at 84.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places South Africa 50th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in South Africa, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 1.0% | — |
| 2003 | 1.0% | +0.0% |
| 2004 | 2.0% | +100.0% |
| 2005 | 4.0% | +100.0% |
| 2006 | 7.0% | +75.0% |
| 2007 | 11.0% | +57.1% |
| 2008 | 15.0% | +36.4% |
| 2009 | 20.0% | +33.3% |
| 2010 | 27.0% | +35.0% |
| 2011 | 35.0% | +29.6% |
| 2012 | 42.0% | +20.0% |
| 2013 | 47.0% | +11.9% |
| 2014 | 52.0% | +10.6% |
| 2015 | 58.0% | +11.5% |
| 2016 | 64.0% | +10.3% |
| 2017 | 70.0% | +9.4% |
| 2018 | 74.0% | +5.7% |
| 2019 | 77.0% | +4.1% |
| 2020 | 79.0% | +2.6% |
| 2021 | 81.0% | +2.5% |
| 2022 | 82.0% | +1.2% |
| 2023 | 83.0% | +1.2% |
| 2024 | 84.0% | +1.2% |
South Africa compared with similar countries
- South Africa's 84.0% is above the median for upper middle income countries, which is 65.0%, 1.3× the median. (39 countries reporting)
- South Africa's 84.0% is below the median for Sub-Saharan Africa, which is 88.5%, 95% of the median. (44 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, female in South Africa changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2004 | +100.0% | 1.0% | 2.0% |
| 2005 | +100.0% | 2.0% | 4.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.1% | 0.0% | 20.0% | 10 |
| 2010s | 54.6% | 27.0% | 77.0% | 10 |
| 2020s | 81.8% | 79.0% | 84.0% | 5 |
Countries ranked near South Africa
More gender data for South Africa
- Child population (UN estimates and projections) 17,151 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.6591 % change on previous year (2030)
- Population 51,011 (2030)
- Working-age population (UN estimates and projections) 51,011 (2030)
- Population (UN estimates and projections), annual growth rate 1.07 % change on previous year (2030)
- Age population, age 00, female, interpolated 570,099 (2025)
- Age population, age 00, male, interpolated 589,533 (2025)
- Age population, age 01, female, interpolated 570,599 (2025)
- Age population, age 01, male, interpolated 589,626 (2025)
- Age population, age 02, female, interpolated 569,634 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in South Africa?
- Access to anti-retroviral drugs, female in South Africa was 84.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in South Africa?
- The highest recorded value was 84.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in South Africa?
- The lowest recorded value was 0.0% in 2000.
- How does South Africa rank for access to anti-retroviral drugs, female?
- South Africa ranks 50th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in South Africa?
- Over the last ten years it is up 61.5%. The long-run trend across the full record is volatile.
- Where does this South Africa data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.